Ticker: RXRX

Company: RECURSION PHARMACEUTICALS, INC.

Person: Blake Borgeson, director

Transaction date: Dec. 2, 2025

Reporting date: Dec. 4, 2025

Average share price: 4.37

Sold 220000.0 shares for 961400.0